4//SEC Filing
Fallon John A. 4
Accession 0001560152-25-000004
CIK 0001267565other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:10 PM ET
Size
12.5 KB
Accession
0001560152-25-000004
Insider Transaction Report
Form 4
Fallon John A.
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Purchase)
2025-11-12−19,853→ 0 totalExercise: $9.33Exp: 2027-05-24→ Common Stock (19,853 underlying) - Exercise/Conversion
Common Stock
2025-11-12$16.49/sh+15,000$247,350→ 79,634 total - Exercise/Conversion
Common Stock
2025-11-12$9.33/sh+19,853$185,228→ 99,487 total - Sale
Common Stock
2025-11-12$47.21/sh−34,853$1,645,536→ 64,634 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-11-12−15,000→ 0 totalExercise: $16.49Exp: 2026-06-09→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.
Documents
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001560152
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:10 PM ET
- Size
- 12.5 KB